Media about us

24 May 2021
Программа «Вести» о проекте «Эфферон»
13 May 2021
Технология компании «Эфферон» оказалась эффективной для терапии осложнений коронавирусной инфекции
13 May 2021
«Фильтры» для микробов: есть ли рынок для новых методов «очищения» крови?
13 May 2021
Итоги работы с устройствами для экстракорпорального очищения крови: Эфферон ЛПС и Эфферон ЦТ
13 May 2021
Ловушка для токсина
13 May 2021
Уникальная разработка: в России создано и уже одобрено новое средство для лечения сепсиса
13 May 2021
Компании «Эфферон» и «Нанолек» обещают купировать последствия коронавируса
Critical Care 2021, 25(Suppl 1): P041
Hemoperfusion with the Efferon CT extracorporeal adsorbers containing mesoporous styrene–divinylbenzene copolymer (SDC) in patients with severe COVID-19
World Journal of Medical Case Reports. Vol. 2, No. 3, 2021, pp. 46-50.
Application of novel device Efferon LPS in hemoperfusion for simultaneous removal of endotoxin and cytokines in a patient with septic shock
Therapeutic archive. 2021; 93 (7): 811-817
Extracorporeal adsorption of cytokines in cytokine release syndrome in a patient with acute lymphoblastic leukemia after therapy with T cells with a chimeric antigen receptor. Clinical observation
General resuscitation. 2020; 16 (6): 31-53.
Application of adsorbent based on a hypercrosslinked styrene-divinylbenzene copolymer with an immobilized LPS-selective ligand in hemoperfusion for the treatment of patients with septic shock
General resuscitation. 2020; 16 (4): 14-20.
Hemosorption carried out by a column filled with hypercrosslinked styrene-divinibenzene copolymer with an immobilized LPS-selective ligand in a complex of intensive treatment of acute lung injury in the surgical treatment of lung cancer (clinical observation)
General resuscitation. 2018; 14 (6): 51-60.
Efficiency and safety of a new product for LPS-selective hemosorption (experimental study)
General resuscitation. 2016; 12 (6): 82-107.
Sorbents for extracorporeal removal of toxic substances and molecules with unwanted biological activity (review)
General resuscitation. 2017; 13 (5): 109-120.
Methods for the determination of bacterial endotoxin in critical care medicine (review).
Invention patent RU 2691413 C1. Date of registration: 26.12.2017
Method for determination of bacterial endotoxin in biological fluids.
Invention patent RU 2653125 C1. Date of registration: 23.05.2017
Polymeric sorbent, method for its production and use.
Publications
30 November 2021
Efferon has participated in MEDICA
26 November 2021
Efferon CT treatment improves patients with severe SARS-CoV-2
09 July 2021
Efferon attracts investments from Fix Ventures
Company news